Aluminum-Laced Granuloma Vaccines’ Alum Adjuvant Path to Brain Found Full Article Study: gaia-health/gaia-blog/2013-04-12/vaccines-alum-adjuvant-path-to-brain-found/ A new study adds a major link in the association of aluminum adjuvants in vaccines with neurological disorders. It demonstrates the pathway along which aluminum in vaccine adjuvants is transferred from the injection site to the brain, where it persists indefinitely. They have also identified a likely carrier and a means by which the process occurs. The use of nanomaterials in humans is not as contemporary as is recently portrayed. For decades, alum, a nanocrystalline compound formed of aluminum oxyhydroxide, has been the most commonly used adjuvant in vaccines. The study is exhaustive, eliminating a wide array of options that might mitigate against their findings. They also focused on two groups to determine if their findings indicate that they’re at particular risk. They include newborns and people with a certain genetic variant. One of the concerns in clinical procedures involving toxic elements on newborn babies is their weak blood-brain barrier. On top of that, the elderly may be at significantly higher risk for aluminum adjuvant-induced neurotoxic harm.
Posted on: Fri, 12 Dec 2014 04:19:10 +0000
Trending Topics
Recently Viewed Topics
© 2015